Edition:
India

Taro Pharmaceutical Industries Ltd (TARO.N)

TARO.N on New York Stock Exchange

116.06USD
23 Jun 2017
Change (% chg)

$2.04 (+1.79%)
Prev Close
$114.02
Open
$114.23
Day's High
$116.40
Day's Low
$114.10
Volume
10,997
Avg. Vol
18,145
52-wk High
$147.81
52-wk Low
$92.28

TARO.N

Chart for TARO.N

About

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical... (more)

Overall

Beta: 0.65
Market Cap(Mil.): $4,701.96
Shares Outstanding(Mil.): 40.51
Dividend: --
Yield (%): --

Financials

  TARO.N Industry Sector
P/E (TTM): 10.50 13.63 17.39
EPS (TTM): 11.05 -- --
ROI: 22.79 -6.95 -5.22
ROE: 22.84 -6.42 -4.48

BUZZ-Taro Pharmaceutical: Shares down after Q4 revenue miss

** Generic drug maker's shares fall as much as 5.9 pct to $105.70; biggest intraday pct drop in more than 5 months

23 May 2017

BRIEF-Taro reports qtrly EPS $2.05

* Qtrly earnings per share $2.05 Source text for Eikon: Further company coverage:

23 May 2017

BRIEF-Crescita Therapeutics announces agreement with Taro Pharmaceuticals for Pliaglis

* Crescita Therapeutics announces agreement with Taro Pharmaceuticals for Pliaglis

25 Apr 2017

BRIEF-Bellus Health to sell subsidiary Thallion Pharmaceuticals to Taro Pharmaceuticals

* Press release - Bellus Health announces the sale of subsidiary Thallion Pharmaceuticals to Taro Pharmaceuticals

17 Mar 2017

India's Sun Pharma Q3 profit falls nearly 5 pct; below estimates

MUMBAI, Feb 14 India's largest drugmaker Sun Pharmaceutical Industries Ltd's third-quarter profit fell below analysts' estimates due to slower sales in the United States, its largest market.

14 Feb 2017

BRIEF-Taro posts quarterly sales of $220.4 million

* Taro Pharmaceutical Industries Ltd qtrly net income per ordinary share from continuing operations attributable to taro $3.42 Source text for Eikon: Further company coverage:

10 Feb 2017

More From Around the Web

Earnings vs. Estimates